MedPath

Urilev I.V.

Brand Name: Urilev I.V.

Generic Name: Levofloxacin (As Hemihydrate)

Active
Registration Number

DRP-3325

Dosage Form

Solution for I.V. Infusion

Issuance Date

June 1, 2022

Expiry Date

November 4, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL (0.5% w/v)
PackagingUSP Type I Clear Colorless Glass x 100 mL (Box of l’s)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Levofloxacin (As Hemihydrate)Active
Monograph: levofloxacin (as hemihydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform